Pharmadrug Inc. — AGM Information 2021

Feb 23, 2021

PHARMADRUG INC.

NOTICE OF ANNUAL GENERAL MEETING

NOTICE is hereby given that the annual general meeting (the " Meeting ") of PHARMADRUG INC. (the " Company "), will be held at the offices of the corporation on Thursday, March 25, 2021 at 10:00 a.m. (Toronto time), The corporation may limit the attendance to comply with applicable health guidelines.

1. To receive and consider the audited consolidated financial statements for the financial year ending December 31, 2019, together with the auditor's report thereon;

2. To elect directors to hold office until the next annual general meeting of the Company;

3. To re-appoint MNP LLP, Chartered Professional Accountants as auditor of the Company, to hold office until the next annual general meeting at a remuneration to be fixed by the directors;

4. To transact such other business as may properly be transacted at such meeting or at any adjournment thereof.

The accompanying management proxy circular provides additional information relating to the matters to be dealt with at the Meeting and is deemed to form part of this notice.

This year, as described in the notice and access notification mailed to shareholders of the Company, the Company has decided to deliver the Meeting materials to shareholders by posting the Meeting materials on the following website: https://www.Pharmadrug.co (the “Website”). The use of this alternative means of delivery is more environmentally friendly as it will help reduce paper use and it will also reduce the Company’s printing and mailing costs. The Meeting materials will be available on the Website as of the day of mailing, which is currently scheduled for February 23, 2021, and will remain on the Website for one full year thereafter. The Meeting materials will also be available on SEDAR at www.sedar.com.

No shareholders will receive paper copies of the Meeting materials unless they specifically request paper copies. Instead all shareholders will receive a notice and access notification which will contain information on how to obtain electronic and paper copies of the Meeting materials in advance of the Meeting. If you wish to receive a paper copy of the Meeting materials or have questions about notice-and-access please call 1-844-499-4482. In order to receive a paper copy in time to vote before the meeting, your request should be received by March 15, 2021.

The record date for the determination of shareholders entitled to receive notice of and to vote at the Meeting is February 8, 2021 (the "Record Date"). Shareholders whose names have been entered in the register of shareholders at the close of business on that date will be entitled to receive notice of and to vote at the Meeting.

The Corporation is actively monitoring the ongoing COVID-19 situation and is sensitive to public health concerns and protocols put in place by federal, provincial and municipal governments. The Corporation will be severely restricting physical access to the Meeting and only registered shareholders and formally appointed proxyholders will be allowed to attend. In order to comply with government orders concerning maximum size of public gatherings and required physical distancing parameters, the Corporation may be unable to admit shareholders to the Meeting. The Corporation strongly encourages registered shareholders and proxyholders not to attend the Meeting in person, and Shareholders are encouraged to vote using one of the methods described in the accompanying management information circular. To further mitigate the risk of the spread of the virus, the Meeting can be accessed by conference call at 1-866-332-3747, Participant Code: 0091269#. This call will be listen-only and shareholders will not be able to vote or speak at, or otherwise participate in the Meeting via the conference call. Given the restrictions in place, the Corporation's board of directors and auditors do not plan to attend the Meeting in person.

DATED at Toronto, Ontario, this 8[th] day of February 2021.

" Daniel Cohen"

_______________________________________ Daniel Cohen Chief Executive Officer